Myriad Genetics
Price & Volume
Stats
See more52W Range | $2.74-$8.59 |
Market Cap | $306M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $557M |
Revenue Growth (YoY) | -20.8% |
Gross Profit (12 Mos) | $379.1M |
Diluted EPS | -$1.18 |
News
See moreYahoo Finance • 13 days ago
3 Healthcare Stocks with Open Questions
Yahoo Finance • 17 days ago
MYRIAD INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Myriad Genetics, Inc. on Behalf of Myriad Stockholders and Encourages Investors to Contact the Firm
Yahoo Finance • 18 days ago
Endometrial Cancer Market Share Analysis and Industry Trends (2026-2031) Featuring Merck, Eisai, Karyopharm Therapeutics, Context Therapeutics, Seagen and More
Yahoo Finance • 25 days ago
Myriad Genetics Q2 Loss Narrows; Revenue Falls 11%
About
CEO | Mr. Samraat S. Raha |
CFO | Mr. Benjamin R. Wheeler |
Address | 322 North 2200 West, Salt Lake City, UT, United States, 84116 |
Sector | Healthcare |
Industry | Diagnostics & Research |
Full-Time Employees | 2,700 |